IDEAS home Printed from https://ideas.repec.org/a/neo/journl/v21y2024i1p47-54.html
   My bibliography  Save this article

Cost and revenue dynamics of clinical trials in state-owned hospitals (2019-2022)

Author

Listed:
  • Yulia Nedelcheva

    (Faculty of Economics, South-West University "Neofit Rilski", Blagoevgrad)

  • Miroslav Nedelchev

    (Medical University, Sofia)

Abstract

Objective: The object of the article is to overview the cost and revenue dynamics of clinical trials conducted in state-owned hospitals. Material and methods: We have created a unique database of clinical trials from public registers of competent authorities. Our overview is based on the protocol content of 550 clinical trials conducted in 62 Bulgarian state-owned hospitals (a total 1,297 medical sites) in the period from 2019 to2022. Results: In the new reality, reduced budget and declined state funding, the attitudes of state-owned hospitals are shifted to the benefits of clinical trials. The primary motive for state-owned hospitals to conduct clinical trials is not revenue, but rather access to new pharmaceutical products and treatment methods.

Suggested Citation

  • Yulia Nedelcheva & Miroslav Nedelchev, 2024. "Cost and revenue dynamics of clinical trials in state-owned hospitals (2019-2022)," Economics and Management, Faculty of Economics, SOUTH-WEST UNIVERSITY "NEOFIT RILSKI", BLAGOEVGRAD, vol. 21(1), pages 47-54.
  • Handle: RePEc:neo:journl:v:21:y:2024:i:1:p:47-54
    DOI: 10.37708/em.swu.v21i1.4
    as

    Download full text from publisher

    File URL: https://em.swu.bg/images/SpisanieIkonomikaupload/SpisanieIkonomika2024/4.%20EM_1_2024_Coast%20and%20Revenue%20dymanics.pdf
    Download Restriction: no

    File URL: https://libkey.io/10.37708/em.swu.v21i1.4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    Bulgaria; trial sites; cost-benefit analysis; health care market;
    All these keywords.

    JEL classification:

    • D61 - Microeconomics - - Welfare Economics - - - Allocative Efficiency; Cost-Benefit Analysis
    • H51 - Public Economics - - National Government Expenditures and Related Policies - - - Government Expenditures and Health
    • I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:neo:journl:v:21:y:2024:i:1:p:47-54. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Vladislav Krastev (email available below). General contact details of provider: https://edirc.repec.org/data/feswubg.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.